Eurofins Scient (OTCMKTS:ERFSF) Shares Down 7% – Time to Sell?

Shares of Eurofins Scient (OTCMKTS:ERFSF) dropped 7% during mid-day trading on Wednesday . The stock traded as low as $74.32 and last traded at $74.32. Approximately 517 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 6,192 shares. The stock had previously closed at $79.9150.

Wall Street Analysts Forecast Growth

ERFSF has been the topic of several recent analyst reports. Citigroup restated a “neutral” rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Eurofins Scient Stock Down 2.8%

The firm’s fifty day moving average is $77.07 and its 200-day moving average is $74.59.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.